We also compared the effects of the prophylactic use of different G-CSF types on the recovery of WBC counts and ANCs and explored independent factors influencing the long duration of leukopenia and neutropenia after the last chemotherapy to guide the use of G-CSF during chemotherapy. The gene discussed is CSF3; the disease is Decreased total neutrophil count.